Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study (Q28258045)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study
scientific article

    Statements

    title
    Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study (English)
    0 references
    author
    Bradley J. Monk
    series ordinal
    3
    object named as
    Bradley J Monk
    0 references
    author name string
    Robert A Burger
    series ordinal
    1
    0 references
    Michael W Sill
    series ordinal
    2
    0 references
    Benjamin E Greer
    series ordinal
    4
    0 references
    Joel I Sorosky
    series ordinal
    5
    0 references
    publication date
    20 November 2007
    0 references
    volume
    25
    0 references
    issue
    33
    0 references
    page(s)
    5165-71
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q28258045&oldid=2032769247"